Volume 81, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Dengue is a major problem worldwide, and improving case management is a significant priority. In consultation with colleagues in Thailand, changes in management of hospitalized dengue cases were introduced in Nicaragua, including oral rather than intravenous (IV) fluids upon admission, continuous monitoring of clinical and laboratory signs, and use of IV fluids principally during the critical phase and colloids in management of shock. Two periods were compared, before (2003) and after (2005) their implementation, to assess impact. In 2003, 182 hospitalized laboratory-confirmed dengue cases 0–14 years of age who presented ≤ 5 days post-symptom onset were included in the study; 46 were enrolled in 2005. Outcomes included significant reductions in days of IV fluid administration ( = 0.0001), number of patients receiving IV fluids ( < 0.0001), and duration of hospitalization ( < 0.0001), and a non-significant reduction in the number of admissions to the intensive care unit from 8 in 2003 to 0 in 2005 ( = 0.36). This study demonstrates concrete gains in dengue patient care and case management.


Article metrics loading...

Loading full text...

Full text loading...



  1. Halstead SB, 1997. Epidemiology of dengue and dengue hemorrhagic fever. Gubler DJ, Kuno G, eds. Dengue and Dengue Hemorrhagic Fever. New York: CAB International, 273–290.
  2. Gubler DJ, 1998. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11 : 480–496.
  3. Gubler DJ, Trent DW, 1994. Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. Infect Agents Dis 2 : 383–393.
  4. Kouri G, Guzman MG, Bravo J, 1986. Hemorrhagic dengue in Cuba: history of an epidemic. PAHO Bull 20 : 24–30.
  5. Kouri G, Valdez M, Arguello L, Guzmán MG, Valdes L, Soler M, Bravo J, 1991. Dengue epidemic in Nicaragua, 1985. Rev Inst Med Trop Sao Paulo 33 : 365–371.
  6. Harris E, Videa E, Perez L, Sandoval E, Tellez Y, Perez ML, Cuadra R, Rocha J, Idiaquez W, Alonso RE, Delgado MA, Campo LA, Acevedo F, Gonzalez A, Amador JJ, Balmaseda A, 2000. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 63 : 5–11.
  7. Balmaseda A, Sandoval E, Pérez L, Gutiérrez CM, Harris E, 1999. Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am J Trop Med Hyg 61 : 893–897.
  8. Hammond SN, Balmaseda A, Perez L, Tellez Y, Saboría SI, Mercado JC, Videa E, Rodríguez Y, Perez MA, Cuadra R, Solano S, Rocha J, Idiaquez W, Gonzalez A, Harris E, 2005. Differences in dengue severity in infants, children, and adults in a three-year hospital-based study in Nicaragua. Am J Trop Med Hyg 73 : 1063–1070.
  9. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV, 1998. Dengue and dengue haemorrhagic fever. Lancet 352 : 971–977.
  10. Kalayanarooj S, 1999. Standardized clinical management: Evidence of reduction of DHF case fatality rate in Thailand. Dengue Bull 23 : 10–16.
  11. Cohen SN, Halstead SB, 1966. Shock associated with dengue infection. I. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand, 1964. J Pediatr 68 : 448–456.
  12. Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT, Tran VD, Nguyen TH, Nguyen VC, Stepniewska K, White NJ, Farrar JJ, 2005. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 353 : 877–889.
  13. Hung NT, Lan NT, 2003. Improvement of case management: a key factor to reduce case fatality rate of dengue hemorrhagic fever in Vietnam. Dengue Bull 27 : 144–148.
  14. Balmaseda A, Guzman MG, Hammond S, Robleto G, Flores C, Tellez Y, Videa E, Saborio S, Perez L, Sandoval E, Rodriguez Y, Harris E, 2003. Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin Diagn Lab Immunol 10 : 317–322.
  15. Balmaseda A, Hammond SN, Tellez Y, Imhoff L, Rodriguez Y, Saborio S, Mercado JC, Perez L, Videa E, Almanza E, Kuan G, Reyes M, Saenz L, Amador JJ, Harris E, 2006. High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health 11 : 935–942.
  16. Fernandez R, Vasquez S, 1990. Serological diagnosis of dengue by an ELISA inhibition method. Mem Inst Oswaldo Cruz 85 : 347–351.
  17. Lanciotti R, Calisher C, Gubler D, Chang G, Vorndam A, 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30 : 545–551.
  18. Seah CLK, Chow VTK, Tan HC, Chan YC, 1995. Rapid, single-step RT-PCR typing of dengue viruses using five NS3 gene primers. J Virol Methods 51 : 193–200.
  19. Kuan G, Gordon AL, Aviles W, Ortega O, Hammond SN, Elizondo D, Nuñez A, Coloma J, Balmaseda A, Harris E, 2009. The Nicaraguan Pediatric Dengue Cohort Study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol. May 12 [Epub ahead of print].
  20. World Health Organization, 1997. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention, and Control. Geneva: World Health Organization.
  21. World Health Organization, 1975. Technical Guide for Diagnosis, Surveillance, Prevention and Control of Dengue Haemorrhagic Fever. Geneva: World Health Organization.
  22. Halstead SB, 2006. Dengue in the Americas and Southeast Asia: do they differ? Rev Panam Salud Publica 20 : 407–415.
  23. Dung NM, Day NP, Tam DT, Loan HT, Chau HT, Minh LN, Diet TV, Bethell DB, Kneen R, Hien TT, White NJ, Farrar JJ, 1999. Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis 29 : 787–794.
  24. Bandyopadhyay S, Lum LC, Kroeger A, 2006. Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health 11 : 1238–1255.
  25. Guzman MG, Kouri G, 2003. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 27 : 1–13.
  26. Penafiel A, Devanand A, Tan HK, Eng P, 2006. Use of molecular adsorbent recirculating system in acute liver failure attributable to dengue hemorrhagic fever. J Intensive Care Med 21 : 369–371.
  27. Molyneux EM, Maitland K, 2005. Intravenous fluids: getting the balance right. N Engl J Med 353 : 941–944.
  28. Ngo NT, Cao XT, Kneen R, Wills B, Nguyen VM, Nguyen TQ, Chu VT, Nguyen TT, Simpson JA, Solomon T, White NJ, Farrar J, 2001. Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 32 : 204–213.
  29. Nguyen TH, Nguyen TL, Lei HY, Lin YS, Le BL, Huang KJ, Lin CF, Do QH, Vu TQ, Lam TM, Yeh TM, Huang JH, Liu CC, Halstead SB, 2006. Volume replacement in infants with dengue hemorrhagic fever/dengue shock syndrome. Am J Trop Med Hyg 74 : 684–691.
  30. Gamble J, Bethell D, Day NP, Loc PP, Phu NH, Gartside IB, Farrar JF, White NJ, 2000. Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock? Clin Sci (Lond) 98 : 211–216.
  31. Harris E, Perez L, Phares C, Perez MA, Idiaquez W, Rocha J, Cuadra R, Hernandez E, Gonzalez A, Amador JJ, Balmaseda A, 2003. Fluid intake and decreased risk for hospitalization for dengue fever, Nicaragua. Emerg Infect Dis 9 : 1003–1006.
  32. Kalayanarooj S, Nimmannitya S, 2004. Guidelines for Dengue Hemorrhagic Fever Case Management. Bangkok: WHO Collaborating Centre for Case Management of Dengue/DHF/DSS Queen Sirikit National Institute of Child Health.
  33. World Health Organization, 2005. Dengue, Dengue Haemorrhagic Fever and Dengue Shock Syndrome in the Context of the Integrated Management of Childhood Illness. Geneva: World Health Organization.
  34. Fonseca BK, Holdgate A, Craig JC, 2004. Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med 158 : 483–490.
  35. Bellemare S, Hartling L, Wiebe N, Russell K, Craig WR, McConnell D, Klassen TP, 2004. Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: a meta-analysis of randomised controlled trials. BMC Med 2 : 11.
  36. Technical Advisory Committee on DHF for South-East Asia and Western Pacific Regions, 1974. Guide for Diagnosis, Treatment and Control of Dengue Fever. Geneva: World Health Organization.
  37. Wills BA, Oragui EE, Dung NM, Loan HT, Chau NV, Farrar JJ, Levin M, 2004. Size and charge characteristics of the protein leak in dengue shock syndrome. J Infect Dis 190 : 810–818.
  38. Bethell DB, Gamble J, Pham PL, Nguyen MD, Tran TH, Ha TH, Tran TN, Dong TH, Gartside IB, White NJ, Day NP, 2001. Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clin Infect Dis 32 : 243–253.
  39. Hung NT, Lan NT, Lei H-Y, Lin Y-S, Lien LB, Huang K-J, Lin C-F, Ha DQ, Huong VTQ, My LT, Yeh T-M, Huang J-H, Liu C-C, Halstead SB, 2006. Volume replacement in infants with dengue hemorrhagic fever/dengue shock syndrome. Am J Trop Med Hyg 74 : 684–691.
  40. Balmaseda A, Hammond S, Pérez L, Tellez Y, Saboria S, Mercado J, Pérez M, Silva S, Rocha C, Harris E, 2006. Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 74 : 449–456.

Data & Media loading...

  • Received : 11 Jan 2009
  • Accepted : 20 May 2009

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error